Resultados de la búsqueda 21-30 of 23933 for Treatment
Patients may receive a single dose to a liver lobe or segmental treatment delivered as a sequence of treatments approximately 30-90 days apart. The ...
The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, and ...
The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell ...
The objectives are to describe the practice patterns of therapeutic agents for treatment of advanced prostate cancer internationally; to assess whether specific ...
... treatment) in Breast Cancer 1/2 genes (BRCA 1/2) and PALB2 associated HER2 ... treatment, post-treatment and (when available) post-mortem soft tissue ...
... treatment. A Study to Evaluate Outcomes of Shoulder Arthroplasty. Rochester, Minn. The purpose of this study is to evaluate the outcomes and complications in ...
Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...
The purpose of this study is to learn about potential side effects facing people who are undergoing treatments for their cancer, specifically, hair loss.
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?